APO Research
Talk to an analyst

APO RESEARCH · REPORT

African Horse Sickness Vaccines

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global African Horse Sickness Vaccines Market Outlook and Growth Opportunities 2026

22 December 2025198 pages

Choose your research edition.

Industry ResearchAfrican Horse Sickness Vaccines Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal African Horse Sickness Vaccines Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal African Horse Sickness Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal African Horse Sickness Vaccines Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal African Horse Sickness Vaccines Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global African Horse Sickness Vaccines market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for African Horse Sickness Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for African Horse Sickness Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for African Horse Sickness Vaccines is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the African Horse Sickness Vaccines market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the African Horse Sickness Vaccines market include Veterinary Serum and Vaccine Research Institute, Onderstepoort Biological Products and Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global African Horse Sickness Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of African Horse Sickness Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents African Horse Sickness Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the African Horse Sickness Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

African Horse Sickness Vaccines Segment by Company

Veterinary Serum and Vaccine Research Institute

Onderstepoort Biological Products

Biopharma

African Horse Sickness Vaccines Segment by Type

Live Vaccines

Killed Vaccines

African Horse Sickness Vaccines Segment by Application

Horses

Donkeys

Mules

African Horse Sickness Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global African Horse Sickness Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions African Horse Sickness Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify African Horse Sickness Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze African Horse Sickness Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global African Horse Sickness Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of African Horse Sickness Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of African Horse Sickness Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the African Horse Sickness Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global African Horse Sickness Vaccines industry.

Chapter 3: Detailed analysis of African Horse Sickness Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of African Horse Sickness Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of African Horse Sickness Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. African Horse Sickness Vaccines Industry Trends Table 2. African Horse Sickness Vaccines Industry Drivers Table 3. African Horse Sickness Vaccines Industry Opportunities and Challenges Table 4. African Horse Sickness Vaccines Industry Restraints Table 5. Global African Horse Sickness Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global African Horse Sickness Vaccines Revenue Share by Company (2021-2026) Table 7. Global African Horse Sickness Vaccines Sales Volume by Company (k units) & (2021-2026) Table 8. Global African Horse Sickness Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global African Horse Sickness Vaccines Average Price (US$/unit) of Company (2021-2026) Table 10. Global African Horse Sickness Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global African Horse Sickness Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global African Horse Sickness Vaccines Company, Product Type & Application Table 13. Global African Horse Sickness Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global African Horse Sickness Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Live Vaccines Table 18. Significant Companies of Killed Vaccines Table 19. Global African Horse Sickness Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global African Horse Sickness Vaccines Sales Volume by Type (2021-2026) & (k units) Table 21. Global African Horse Sickness Vaccines Sales Volume by Type (2027-2032) & (k units) Table 22. Global African Horse Sickness Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global African Horse Sickness Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global African Horse Sickness Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global African Horse Sickness Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global African Horse Sickness Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global African Horse Sickness Vaccines Sales Value Share by Type (2021-2026) Table 28. Global African Horse Sickness Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Horses Table 30. Significant Companies of Donkeys Table 31. Significant Companies of Mules Table 32. Global African Horse Sickness Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 33. Global African Horse Sickness Vaccines Sales Volume by Application (2021-2026) & (k units) Table 34. Global African Horse Sickness Vaccines Sales Volume by Application (2027-2032) & (k units) Table 35. Global African Horse Sickness Vaccines Sales Volume Share by Application (2021-2026) Table 36. Global African Horse Sickness Vaccines Sales Volume Share by Application (2027-2032) Table 37. Global African Horse Sickness Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global African Horse Sickness Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global African Horse Sickness Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global African Horse Sickness Vaccines Sales Value Share by Application (2021-2026) Table 41. Global African Horse Sickness Vaccines Sales Value Share by Application (2027-2032) Table 42. Global African Horse Sickness Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 43. Global African Horse Sickness Vaccines Sales by Region (2021-2026) & (k units) Table 44. Global African Horse Sickness Vaccines Sales Market Share by Region (2021-2026) Table 45. Global African Horse Sickness Vaccines Sales by Region (2027-2032) & (k units) Table 46. Global African Horse Sickness Vaccines Sales Market Share by Region (2027-2032) Table 47. Global African Horse Sickness Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global African Horse Sickness Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global African Horse Sickness Vaccines Sales Value Share by Region (2021-2026) Table 50. Global African Horse Sickness Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global African Horse Sickness Vaccines Sales Value Share by Region (2027-2032) Table 52. Global African Horse Sickness Vaccines Market Average Price (US$/unit) by Region (2021-2026) Table 53. Global African Horse Sickness Vaccines Market Average Price (US$/unit) by Region (2027-2032) Table 54. Global African Horse Sickness Vaccines Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 55. Global African Horse Sickness Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global African Horse Sickness Vaccines Sales by Country (2021-2026) & (k units) Table 57. Global African Horse Sickness Vaccines Sales Market Share by Country (2021-2026) Table 58. Global African Horse Sickness Vaccines Sales by Country (2027-2032) & (k units) Table 59. Global African Horse Sickness Vaccines Sales Market Share by Country (2027-2032) Table 60. Global African Horse Sickness Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global African Horse Sickness Vaccines Sales Value Market Share by Country (2021-2026) Table 62. Global African Horse Sickness Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global African Horse Sickness Vaccines Sales Value Market Share by Country (2027-2032) Table 64. Veterinary Serum and Vaccine Research Institute Company Information Table 65. Veterinary Serum and Vaccine Research Institute Business Overview Table 66. Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Product Portfolio Table 68. Veterinary Serum and Vaccine Research Institute Recent Development Table 69. Onderstepoort Biological Products Company Information Table 70. Onderstepoort Biological Products Business Overview Table 71. Onderstepoort Biological Products African Horse Sickness Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Onderstepoort Biological Products African Horse Sickness Vaccines Product Portfolio Table 73. Onderstepoort Biological Products Recent Development Table 74. Biopharma Company Information Table 75. Biopharma Business Overview Table 76. Biopharma African Horse Sickness Vaccines Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Biopharma African Horse Sickness Vaccines Product Portfolio Table 78. Biopharma Recent Development Table 79. Key Raw Materials Table 80. Raw Materials Key Suppliers Table 81. African Horse Sickness Vaccines Distributors List Table 82. African Horse Sickness Vaccines Customers List Table 83. Research Programs/Design for This Report Table 84. Authors List of This Report Table 85. Secondary Sources Table 86. Primary Sources List of Figures Figure 1. African Horse Sickness Vaccines Product Image Figure 2. Global African Horse Sickness Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global African Horse Sickness Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global African Horse Sickness Vaccines Sales (2021-2032) & (k units) Figure 5. Global African Horse Sickness Vaccines Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global African Horse Sickness Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Live Vaccines Image Figure 10. Killed Vaccines Image Figure 11. Global African Horse Sickness Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global African Horse Sickness Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global African Horse Sickness Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global African Horse Sickness Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global African Horse Sickness Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global African Horse Sickness Vaccines Sales Value Share by Type (2021-2032) Figure 17. Horses Image Figure 18. Donkeys Image Figure 19. Mules Image Figure 20. Global African Horse Sickness Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 21. Global African Horse Sickness Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global African Horse Sickness Vaccines Sales Volume Share by Application (2021-2032) Figure 23. Global African Horse Sickness Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global African Horse Sickness Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global African Horse Sickness Vaccines Sales Value Share by Application (2021-2032) Figure 26. Global African Horse Sickness Vaccines Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 27. Global African Horse Sickness Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global African Horse Sickness Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global African Horse Sickness Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America African Horse Sickness Vaccines Sales Value (2021-2032) & (US$ Million) Figure 31. North America African Horse Sickness Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe African Horse Sickness Vaccines Sales Value (2021-2032) & (US$ Million) Figure 33. Europe African Horse Sickness Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific African Horse Sickness Vaccines Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific African Horse Sickness Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America African Horse Sickness Vaccines Sales Value (2021-2032) & (US$ Million) Figure 37. South America African Horse Sickness Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa African Horse Sickness Vaccines Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa African Horse Sickness Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. African Horse Sickness Vaccines Value Chain Figure 125. Manufacturing Cost Structure Figure 126. African Horse Sickness Vaccines Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Live Vaccines
  • Killed Vaccines
Applications
  • Horses
  • Donkeys
  • Mules
Companies covered
  • Veterinary Serum and Vaccine Research Institute
  • Onderstepoort Biological Products
  • Biopharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global African Horse Sickness Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global African Horse Sickness Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global African Horse Sickness Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 African Horse Sickness Vaccines Market Dynamics
  1. 2.1 African Horse Sickness Vaccines Industry Trends
  2. 2.2 African Horse Sickness Vaccines Industry Drivers
  3. 2.3 African Horse Sickness Vaccines Industry Opportunities and Challenges
  4. 2.4 African Horse Sickness Vaccines Industry Restraints
3 African Horse Sickness Vaccines Market by Company
  1. 3.1 Global African Horse Sickness Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global African Horse Sickness Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global African Horse Sickness Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global African Horse Sickness Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global African Horse Sickness Vaccines Company Ranking (2024-2026)
  6. 3.6 Global African Horse Sickness Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global African Horse Sickness Vaccines Company Product Type and Application
  8. 3.8 Global African Horse Sickness Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global African Horse Sickness Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 African Horse Sickness Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 African Horse Sickness Vaccines Market by Type
  1. 4.1 African Horse Sickness Vaccines Type Introduction
  2. 4.1.1 Live Vaccines
  3. 4.1.2 Killed Vaccines
  4. 4.2 Global African Horse Sickness Vaccines Sales Volume by Type
  5. 4.2.1 Global African Horse Sickness Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global African Horse Sickness Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global African Horse Sickness Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global African Horse Sickness Vaccines Sales Value by Type
  9. 4.3.1 Global African Horse Sickness Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global African Horse Sickness Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global African Horse Sickness Vaccines Sales Value Share by Type (2021-2032)
5 African Horse Sickness Vaccines Market by Application
  1. 5.1 African Horse Sickness Vaccines Application Introduction
  2. 5.1.1 Horses
  3. 5.1.2 Donkeys
  4. 5.1.3 Mules
  5. 5.2 Global African Horse Sickness Vaccines Sales Volume by Application
  6. 5.2.1 Global African Horse Sickness Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global African Horse Sickness Vaccines Sales Volume by Application (2021-2032)
  8. 5.2.3 Global African Horse Sickness Vaccines Sales Volume Share by Application (2021-2032)
  9. 5.3 Global African Horse Sickness Vaccines Sales Value by Application
  10. 5.3.1 Global African Horse Sickness Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global African Horse Sickness Vaccines Sales Value by Application (2021-2032)
  12. 5.3.3 Global African Horse Sickness Vaccines Sales Value Share by Application (2021-2032)
6 African Horse Sickness Vaccines Regional Sales and Value Analysis
  1. 6.1 Global African Horse Sickness Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global African Horse Sickness Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global African Horse Sickness Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global African Horse Sickness Vaccines Sales by Region (2027-2032)
  5. 6.3 Global African Horse Sickness Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global African Horse Sickness Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global African Horse Sickness Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global African Horse Sickness Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global African Horse Sickness Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America African Horse Sickness Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America African Horse Sickness Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe African Horse Sickness Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe African Horse Sickness Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific African Horse Sickness Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific African Horse Sickness Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America African Horse Sickness Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America African Horse Sickness Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa African Horse Sickness Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa African Horse Sickness Vaccines Sales Value Share by Country, 2025 VS 2032
7 African Horse Sickness Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global African Horse Sickness Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global African Horse Sickness Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global African Horse Sickness Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global African Horse Sickness Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global African Horse Sickness Vaccines Sales by Country (2027-2032)
  6. 7.4 Global African Horse Sickness Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global African Horse Sickness Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global African Horse Sickness Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt African Horse Sickness Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt African Horse Sickness Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt African Horse Sickness Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Veterinary Serum and Vaccine Research Institute
  2. 8.1.1 Veterinary Serum and Vaccine Research Institute Company Information
  3. 8.1.2 Veterinary Serum and Vaccine Research Institute Business Overview
  4. 8.1.3 Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Veterinary Serum and Vaccine Research Institute African Horse Sickness Vaccines Product Portfolio
  6. 8.1.5 Veterinary Serum and Vaccine Research Institute Recent Developments
  7. 8.2 Onderstepoort Biological Products
  8. 8.2.1 Onderstepoort Biological Products Company Information
  9. 8.2.2 Onderstepoort Biological Products Business Overview
  10. 8.2.3 Onderstepoort Biological Products African Horse Sickness Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Onderstepoort Biological Products African Horse Sickness Vaccines Product Portfolio
  12. 8.2.5 Onderstepoort Biological Products Recent Developments
  13. 8.3 Biopharma
  14. 8.3.1 Biopharma Company Information
  15. 8.3.2 Biopharma Business Overview
  16. 8.3.3 Biopharma African Horse Sickness Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Biopharma African Horse Sickness Vaccines Product Portfolio
  18. 8.3.5 Biopharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 African Horse Sickness Vaccines Value Chain Analysis
  2. 9.1.1 African Horse Sickness Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 African Horse Sickness Vaccines Sales Mode & Process
  6. 9.2 African Horse Sickness Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 African Horse Sickness Vaccines Distributors
  9. 9.2.3 African Horse Sickness Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst